Position in NTRA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$885,469
+$282,100 QoQ
Shares Held
3,262
+8.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#455
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $40,569,660 across 16 Diagnostics & Research names. NTRA ranks #15 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,026 | $6,530,715 | |
| 2 | ILMN |
Illumina, Inc.
|
22,808 | $4,010,330 | |
| 3 | DHR |
Danaher Corp /De/
|
19,635 | $3,740,074 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,051 | $3,190,059 | |
| 5 | A |
Agilent Technologies, Inc.
|
23,182 | $3,079,265 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
13,010 | $2,950,537 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,384 | $2,779,276 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
4,777 | $2,514,803 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $885,469 | 3,262 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $603,369 | 3,017 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $557,834 | 2,435 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $447,818 | 2,782 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||